BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 33033234)

  • 21. Induction of sonic hedgehog mediators by transforming growth factor-beta: Smad3-dependent activation of Gli2 and Gli1 expression in vitro and in vivo.
    Dennler S; André J; Alexaki I; Li A; Magnaldo T; ten Dijke P; Wang XJ; Verrecchia F; Mauviel A
    Cancer Res; 2007 Jul; 67(14):6981-6. PubMed ID: 17638910
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patched1 inhibits epidermal progenitor cell expansion and basal cell carcinoma formation by limiting Igfbp2 activity.
    Villani RM; Adolphe C; Palmer J; Waters MJ; Wainwright BJ
    Cancer Prev Res (Phila); 2010 Oct; 3(10):1222-34. PubMed ID: 20858761
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ABT-199 inhibits Hedgehog pathway by acting as a competitive inhibitor of oxysterol, rather as a BH3 mimetic.
    Wang J; Zhang Y; Huang WJ; Yang J; Tang WG; Huang TM; Tan WF
    Acta Pharmacol Sin; 2021 Jun; 42(6):1005-1013. PubMed ID: 32855528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protein kinase A activation inhibits oncogenic Sonic hedgehog signalling and suppresses basal cell carcinoma of the skin.
    Makinodan E; Marneros AG
    Exp Dermatol; 2012 Nov; 21(11):847-52. PubMed ID: 23163650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human GLI2 and GLI1 are part of a positive feedback mechanism in Basal Cell Carcinoma.
    Regl G; Neill GW; Eichberger T; Kasper M; Ikram MS; Koller J; Hintner H; Quinn AG; Frischauf AM; Aberger F
    Oncogene; 2002 Aug; 21(36):5529-39. PubMed ID: 12165851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor-Derived Suppressor of Fused Mutations Reveal Hedgehog Pathway Interactions.
    Urman NM; Mirza A; Atwood SX; Whitson RJ; Sarin KY; Tang JY; Oro AE
    PLoS One; 2016; 11(12):e0168031. PubMed ID: 28030567
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A cell identity switch allows residual BCC to survive Hedgehog pathway inhibition.
    Biehs B; Dijkgraaf GJP; Piskol R; Alicke B; Boumahdi S; Peale F; Gould SE; de Sauvage FJ
    Nature; 2018 Oct; 562(7727):429-433. PubMed ID: 30297801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antitumoral effects of calcitriol in basal cell carcinomas involve inhibition of hedgehog signaling and induction of vitamin D receptor signaling and differentiation.
    Uhmann A; Niemann H; Lammering B; Henkel C; Hess I; Nitzki F; Fritsch A; Prüfer N; Rosenberger A; Dullin C; Schraepler A; Reifenberger J; Schweyer S; Pietsch T; Strutz F; Schulz-Schaeffer W; Hahn H
    Mol Cancer Ther; 2011 Nov; 10(11):2179-88. PubMed ID: 21878656
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hedgehog signaling is a novel therapeutic target in tamoxifen-resistant breast cancer aberrantly activated by PI3K/AKT pathway.
    Ramaswamy B; Lu Y; Teng KY; Nuovo G; Li X; Shapiro CL; Majumder S
    Cancer Res; 2012 Oct; 72(19):5048-59. PubMed ID: 22875023
    [TBL] [Abstract][Full Text] [Related]  

  • 30. c-FOS drives reversible basal to squamous cell carcinoma transition.
    Kuonen F; Li NY; Haensel D; Patel T; Gaddam S; Yerly L; Rieger K; Aasi S; Oro AE
    Cell Rep; 2021 Oct; 37(1):109774. PubMed ID: 34610301
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The intrahepatic signalling niche of hedgehog is defined by primary cilia positive cells during chronic liver injury.
    Grzelak CA; Martelotto LG; Sigglekow ND; Patkunanathan B; Ajami K; Calabro SR; Dwyer BJ; Tirnitz-Parker JE; Watkins DN; Warner FJ; Shackel NA; McCaughan GW
    J Hepatol; 2014 Jan; 60(1):143-51. PubMed ID: 23978713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cross-Talk between Wnt and Hh Signaling Pathways in the Pathology of Basal Cell Carcinoma.
    Noubissi FK; Yedjou CG; Spiegelman VS; Tchounwou PB
    Int J Environ Res Public Health; 2018 Jul; 15(7):. PubMed ID: 29987229
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gli1 protein is expressed in basal cell carcinomas, outer root sheath keratinocytes and a subpopulation of mesenchymal cells in normal human skin.
    Ghali L; Wong ST; Green J; Tidman N; Quinn AG
    J Invest Dermatol; 1999 Oct; 113(4):595-9. PubMed ID: 10504446
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction of hedgehog and vitamin D signaling pathways in basal cell carcinomas.
    Albert B; Hahn H
    Adv Exp Med Biol; 2014; 810():329-41. PubMed ID: 25207374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Segmental basaloid follicular hamartomas derive from a post-zygotic SMO p.L412F pathogenic variant and express hair follicle development-related proteins in a pattern that distinguish them from basal cell carcinomas.
    Atzmony L; Ugwu N; Bercovitch LG; Robinson-Bostom L; Ko CJ; Myung P; Choate KA
    Am J Med Genet A; 2022 Dec; 188(12):3525-3530. PubMed ID: 35972041
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of hedgehog signaling by Myc-interacting zinc finger protein 1, Miz1.
    Lu J; Chen M; Ren XR; Wang J; Lyerly HK; Barak L; Chen W
    PLoS One; 2013; 8(5):e63353. PubMed ID: 23671675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hedgehog- and mTOR-targeted therapies for advanced basal cell carcinomas.
    Piérard-Franchimont C; Hermanns-Lê T; Paquet P; Herfs M; Delvenne P; Piérard GE
    Future Oncol; 2015 Nov; 11(22):2997-3002. PubMed ID: 26437034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Smoothened variants explain the majority of drug resistance in basal cell carcinoma.
    Atwood SX; Sarin KY; Whitson RJ; Li JR; Kim G; Rezaee M; Ally MS; Kim J; Yao C; Chang AL; Oro AE; Tang JY
    Cancer Cell; 2015 Mar; 27(3):342-53. PubMed ID: 25759020
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dissecting the oncogenic potential of Gli2: deletion of an NH(2)-terminal fragment alters skin tumor phenotype.
    Sheng H; Goich S; Wang A; Grachtchouk M; Lowe L; Mo R; Lin K; de Sauvage FJ; Sasaki H; Hui CC; Dlugosz AA
    Cancer Res; 2002 Sep; 62(18):5308-16. PubMed ID: 12235001
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of CRD-BP in the growth of human basal cell carcinoma cells.
    Noubissi FK; Kim T; Kawahara TN; Aughenbaugh WD; Berg E; Longley BJ; Athar M; Spiegelman VS
    J Invest Dermatol; 2014 Jun; 134(6):1718-1724. PubMed ID: 24468749
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.